USPTO serial 97779299
SYNETS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 30, 2024
- Examiner
- BECHHOFER, YOCHEVED D
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SYNETS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jennifer A. Visintine
Jennifer A. Visintine THOMPSON COBURN LLPONE US BANK PLAZAST. LOUIS, MO 63101UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Food supplements, namely, anti-oxidants; Capsules sold empty for pharmaceutical purposes; Capsules sold empty for veterinary pharmaceutical preparations; Chemical preparations for pharmaceutical use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Collagen based medicated supplements; Decoctions for pharmaceutical purposes to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Antioxidants in the nature of dietary supplements; Dietary protein supplements; Dietary supplements; Dietary supplements for animals; Dietary supplements with a cosmetic effect; Effervescent pharmaceutical preparations to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Food supplements for medical purposes; Herbal dietary supplements; Dietary nutritional supplements; Nutritional supplements; Medicinal plant compounds for use as dietary supplements; Plant compounds for use as veterinary dietary supplements ; Plant extracts being dietary supplements; Medicated lozenges for pharmaceutical purposes; skin lotions for pharmaceutical purposes; Pharmaceutical drugs to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical preparations containing vitamins to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical preparations for health care to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical preparations for human use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical preparations for oral use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical preparations for skin care; Pharmaceutical preparations for veterinary use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Chemical products for pharmaceutical use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Natural pharmaceutical products to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical products to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Tablets being pharmaceuticals to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Food supplements for animals in the nature of vitamins; Vitamin supplements; Dietary food supplements; Nutritional drinks being dietary food supplements; Food supplements in the nature of dietary supplements | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 30, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 30, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 14, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 14, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 24, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 10, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 9, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 9, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 9, 2024 | ALIE | ASSIGNED TO LIE | — |
| Nov 17, 2023 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Nov 12, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 12, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 12, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Nov 8, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 8, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 8, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 8, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 1, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 22, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 7, 2023 | NWAP | NEW APPLICATION ENTERED | — |